Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2026-02-01 @ 11:29 PM
Study NCT ID:
NCT01582061
Status:
COMPLETED
Last Update Posted:
2018-06-19
First Post:
2012-04-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cushing's Disease | View |